Search results for: COVID-19 Research
Filter search results
Lunchtime Seminar: Capturing Preferences about Treatment at the End of Life
9 April 2013
…OHE hosted a Lunchtime Seminar that examined both the approach and the results of research to date. OHE’s Koonal Shah is a co-investigator in research intended to define public preferences…
Adult Versus Adolescent Preferences for EQ-5D-Y Health States
15 April 2019
…health in children. He discussed some of the normative, perspective and methodological issues associated with this kind of health valuation research. He then presented an overview of recent research undertaken…
New Drugs to Tackle Antimicrobial Resistance: Breaking the European Deadlock: Part 1 – Defining Objectives
25 May 2023
…responsibility of the authors. Related Research Firth, I., Pan, J., Towse, A., Steuten, L., 2023. A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance. OHE Contract Research…
Narrowing the Gap between provision and need for medicines in developing countries
1 February 2000
…competitions for proposals from academic and industry researchers to conduct the necessary research at their respective facilities. The new Medicines for Malaria Venture (MMV) is an example of the latter….
OHE at AES: Medicines Prices in the UK, Health Inequalities in Costa Rica
25 June 2013
…last week reported the results of four research projects. Jorge Mestre-Ferrandiz, OHE’s Director of Consulting, presented OHE’s recent research on projecting medicines expenditures in the NHS using a bottom-up, rather…
How Will Demands for Effectiveness Evidence Change Drug Development?
23 April 2014
…as used by clinicians in everyday practice. Such research is commonly known as comparative effectiveness research (CER) in the US and relative effectiveness (RE) research in Europe. The project reported…
Is the revised Congressional Budget Office model of new drug development fit for purpose?
6 May 2026
…reforms on research and development (R&D) incentives. The Congressional Budget Office (CBO)’s model of new drug development is designed to help Congress assess how legislation that affects pharmaceutical industry revenues…
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
1 July 2018
Using a multidisciplinary methodological approach combining a theoretical economic framework with uptake/market share analyses by country and interviews, this OHE research concludes that: (i) IP incentives for R&D may have…
A Comparison of Alternative Variants of the Lead and Lag Time TTO
12 January 2010
…methodology, are reported in this OHE Research Paper. The aims of this research… OHE was awarded a UK Department of Health grant to further develop three aspects of health status…